| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 352,5 k € | +1.4% | 347,7 k € | +10.4% | 315,0 k € | +11.7% | 282,0 k € | -0.3% | 282,8 k € | +35.9% | 208,1 k € | -24.9% | 277,2 k € | +11.0% | 249,6 k € | -2.6% | 256,2 k € | +7.1% | 239,3 k € | +9.4% | 218,7 k € | -3.7% | 227,2 k € | -0.3% | 227,8 k € | +6.4% | 214,1 k € | +0.5% | 213,1 k € | +6.8% | 199,5 k € | -5.8% | 211,7 k € | +13.6% | 186,4 k € | +42.7% | 130,7 k € | -17.5% | 158,4 k € | |
| EBITDA | 351,0 k € | +1.4% | 346,3 k € | +10.5% | 313,4 k € | +11.6% | 280,7 k € | -0.2% | 281,4 k € | +36.0% | 206,9 k € | -24.9% | 275,7 k € | +11.1% | 248,1 k € | -2.6% | 254,8 k € | +7.1% | 237,9 k € | +9.6% | 217,0 k € | -3.7% | 225,2 k € | -0.2% | 225,8 k € | +6.4% | 212,2 k € | +0.4% | 211,2 k € | +9.6% | 192,7 k € | -8.7% | 211,0 k € | +13.6% | 185,7 k € | +42.9% | 130,0 k € | -17.6% | 157,7 k € | |
| Operating profit | 350,8 k € | +1.4% | 345,9 k € | +10.6% | 312,7 k € | +11.7% | 280,1 k € | -0.3% | 280,9 k € | +35.9% | 206,7 k € | -25.0% | 275,7 k € | +11.1% | 248,1 k € | -2.6% | 254,8 k € | +7.1% | 237,9 k € | +9.6% | 217,0 k € | +2.2% | 212,3 k € | -0.2% | 212,8 k € | +6.8% | 199,1 k € | +0.6% | 197,9 k € | +9.9% | 180,1 k € | -14.7% | 211,0 k € | +13.6% | 185,7 k € | +42.9% | 130,0 k € | -17.6% | 157,7 k € | |
| Profit/loss | 250,4 k € | +0.6% | 249,0 k € | +12.6% | 221,1 k € | +16.9% | 189,2 k € | -4.1% | 197,3 k € | +42.0% | 138,9 k € | -24.7% | 184,5 k € | +10.2% | 167,5 k € | +8.4% | 154,4 k € | +10.5% | 139,8 k € | +3.6% | 134,9 k € | +1.3% | 133,2 k € | -6.9% | 143,1 k € | +6.7% | 134,2 k € | -3.2% | 138,6 k € | +8.9% | 127,3 k € | -12.4% | 145,2 k € | +14.5% | 126,8 k € | +43.1% | 88,6 k € | -21.0% | 112,2 k € | |
| Equity | 2,0 M € | +9.2% | 1,9 M € | +15.4% | 1,6 M € | +15.8% | 1,4 M € | +15.6% | 1,2 M € | +6.1% | 1,1 M € | +3.2% | 1,1 M € | +20.1% | 919,7 k € | -12.2% | 1,0 M € | +17.3% | 893,1 k € | +18.6% | 753,3 k € | +21.8% | 618,4 k € | +20.0% | 515,1 k € | +8.3% | 475,8 k € | +39.0% | 342,4 k € | +68.0% | 203,8 k € | -26.3% | 276,6 k € | -1.7% | 281,4 k € | +80.2% | 156,1 k € | -12.0% | 177,5 k € | |
| Total assets | 2,2 M € | +14.3% | 1,9 M € | +15.4% | 1,6 M € | +14.8% | 1,4 M € | +0.1% | 1,4 M € | +23.2% | 1,2 M € | +0.5% | 1,2 M € | +20.4% | 962,3 k € | -11.5% | 1,1 M € | +9.3% | 994,2 k € | +15.4% | 861,5 k € | +16.5% | 739,7 k € | +6.2% | 696,4 k € | +41.2% | 493,2 k € | +36.5% | 361,3 k € | -14.8% | 424,2 k € | -1.8% | 432,0 k € | +38.7% | 311,5 k € | +4.8% | 297,3 k € | +43.9% | 206,7 k € | |
| Cash | 949,3 k € | -19.4% | 1,2 M € | +38.1% | 853,1 k € | -23.6% | 1,1 M € | -4.4% | 1,2 M € | +23.9% | 942,9 k € | -7.6% | 1,0 M € | +21.3% | 841,5 k € | -12.4% | 960,2 k € | +9.0% | 881,0 k € | +16.3% | 757,2 k € | +23.0% | 615,6 k € | +11.1% | 554,1 k € | +51.9% | 364,8 k € | +73.6% | 210,1 k € | -25.3% | 281,2 k € | -9.7% | 311,5 k € | +55.4% | 200,4 k € | -7.5% | 216,6 k € | +88.6% | 114,9 k € | |
| Debts | 135,3 k € | +296.7% | 34,1 k € | +15.4% | 29,5 k € | -21.8% | 37,8 k € | -83.2% | 225,2 k € | +822.0% | 24,4 k € | -54.9% | 54,1 k € | +27.1% | 42,6 k € | +8.6% | 39,2 k € | -61.2% | 101,1 k € | -6.6% | 108,2 k € | -10.8% | 121,3 k € | -33.1% | 181,3 k € | +943.9% | 17,4 k € | -7.8% | 18,8 k € | -91.5% | 220,4 k € | +41.8% | 155,4 k € | +415.5% | 30,2 k € | -78.6% | 141,2 k € | +384.5% | 29,1 k € | |
Private limited company · Bornem · incorporated on 15/01/2001
Private limited company profitable and well capitalised. Cash position declining (-19.4%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
DR. SABINE VERGAUWEN is a Private limited company incorporated in 2001. Its main activity is: Activités des laboratoires médicaux. Its registered office is in Bornem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette